How QA Supported a Client Past $1B in Revenue

One of the highest-stakes engagements behind the $1B+ in revenue we have supported across embedded QA engagements was a payments client scaling well past its original transaction volume. The product's feature set had barely changed. The risk underneath it had changed completely.

What breaks first when a product scales past high transaction volume?

The paths that break first at high volume are usually the ones nobody re-tested after they were first built: payment retries, webhook delivery, and anything relying on a queue or a third-party rate limit that never mattered when usage was low. Functional correctness rarely fails first. Capacity and timing do.

Why a stable feature set does not mean stable risk

Nothing about the checkout flow's code had changed in months, and every existing test for it still passed. What had changed was the volume moving through it: more concurrent requests, more retries hitting the same idempotency key, more chances for a webhook to arrive twice or a rate limit to get hit mid-transaction. None of that shows up in a functional test run at low volume, since the defect only exists at the volume the test never simulated.

What the QA priorities shifted to

• Load and concurrency testing on payment and webhook paths, not just functional correctness
• Retry and idempotency behavior under failure, so a duplicate webhook or timeout could not double-charge or double-fulfill an order
• Monitoring tied directly to test coverage, so a regression at 2am got caught before a support ticket did
• Rollback and incident-response steps rehearsed as part of the release process, not written down and never practiced
• Risk-based regression reweighted every quarter as usage patterns shifted, instead of a checklist frozen at launch

The result

The client went through its highest-volume quarter to date without a single payment-path incident reaching a customer. That is the specific outcome this engagement contributed to the $1B+ figure we track across embedded engagements combined, not one dramatic fix, but a QA process that scaled its priorities alongside the product's actual risk instead of testing the same way at ten times the volume.

The mistake most teams make scaling QA with the product

The common mistake is scaling engineering headcount and infrastructure for growth while leaving the test suite exactly as it was, on the assumption that if a path worked at one-tenth the volume, it still works now. Volume is not just a bigger number running through the same code, it is a different set of failure modes entirely, and a test suite built for correctness alone will not catch a single one of them.

Scaling QA alongside a product is not about testing more, it is about testing for the failure modes that only exist at the new volume, the same discipline behind any risk-based regression suite, just applied to growth instead of a release calendar.